Log In
BCIQ
Print this Print this
 

MEDI9447

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionCD73 mAb
Molecular Target Ecto-5'-nucleotidase (NT5E) (NT) (CD73)
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today